Clinical Trials Directory

Trials / Completed

CompletedNCT01839292

ComVi and D-type Stent in Malignant GOO

A Newly Designed Conformable Uncovered Versus Covered Self-expandable Metallic Stent for Palliation of Malignant Gastric Outlet Obstruction: a Prospective, Randomized Multicenter Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
89 (actual)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Covered self-expandable metallic stents (SEMS) have been used to prevent tumor ingrowth, a common complication of uncovered SEMSs. However, they have revealed a high incidence of stent migration in patients with unresectable malignant gastric outlet obstruction (GOO). A conformable covered SEMS was introduced to overcome both stent migration and tumor ingrowth. The aims of this study were to evaluate the clinical outcomes of newly designed conformable covered and uncovered SEMS for palliation of malignant GOO.

Conditions

Interventions

TypeNameDescription
DEVICEuncovered D-type stent insertion
DEVICEdouble-layered ComVi stent insertion

Timeline

Start date
2010-04-01
Primary completion
2012-08-01
First posted
2013-04-24
Last updated
2013-04-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01839292. Inclusion in this directory is not an endorsement.